Maternal-Fetal Medicine (Apr 2020)

Prevention of Perinatal Group B Streptococcus Infections

  • Shang-Rong Fan,
  • Umber Tasneem,
  • Xiao-Ping Liu,
  • Shao-Mei Yan,
  • Yang Pan,
  • Dan-Dan Shi

DOI
https://doi.org/10.1097/FM9.0000000000000041
Journal volume & issue
Vol. 2, no. 2
pp. 100 – 109

Abstract

Read online

Abstract. Group B streptococcus (GBS) is a leading cause of neonatal infection. Maternal vaginal-rectal colonization with GBS during the intrapartum period is a prerequisite for GBS early-onset disease (EOD). The obstetric measures for effective prevention of GBS EOD include universal prenatal screening by vaginal-rectal culture, correct specimen collection and processing, appropriate implementation of intrapartum antibiotic prophylaxis, and coordination with pediatric care providers. It is now recommended to universal screen GBS between 360/7 and 376/7 weeks of gestation and to identify groups of women who are eligible for intravenous intrapartum antibiotic prophylaxis as a means of preventing GBS EOD.